| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Supplementary Table 14. Gene-set enrichment result by FUMA for T1 Based on GWAS summary statistics, FUMA mapped genes based on the position of Lead SNP, Independent Significant SNP. With all the unique genes associated with 128 UDIPs, gene-set enrichment analysis was performed in FUMA. | |||||||||||||||||||||||||
2 | Geneset enrichment result T1 | |||||||||||||||||||||||||
3 | Category | GeneSet | N_genes | N_overlap | p | adjP | genes | link | ||||||||||||||||||
4 | GWAScatalog | Autism spectrum disorder or schizophrenia | 612 | 71 | 7.25E-32 | 4.39E-29 | TMEM180:ACTR1A:SUFU:TRIM8:ARL3:HEXIM1:MAGI1:FOXP1:BANK1:SLC39A8:BTN3A2:BTN2A2:BTN3A1:BTN3A3:BTN2A1:BTN1A1:HMGN4:ABT1:ZNF322:POM121L2:ZNF391:ZNF184:HIST1H2BL:HIST1H2AI:HIST1H3H:HIST1H2AJ:HIST1H2BM:HIST1H4J:HIST1H4K:HIST1H2AK:HIST1H2BN:HIST1H2AL:HIST1H1B:HIST1H3I:HIST1H4L:HIST1H3J:HIST1H2AM:HIST1H2BO:OR2B2:OR2B6:ZNF165:ZSCAN16:ZKSCAN8:ZSCAN9:ZKSCAN4:NKAPL:PGBD1:ZSCAN31:ZKSCAN3:ZSCAN12:ZSCAN23:GPX6:SCAND3:TRIM27:C6orf100:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR14J1:OR5V1:OR12D3:OR12D2:OR11A1:OR10C1:OR2H1:MAS1L:UBD:GABBR1:OR2H2 | |||||||||||||||||||
5 | GWAScatalog | General factor of neuroticism | 78 | 17 | 6.50E-13 | 1.97E-10 | ARHGAP27:CRHR1:MAPT:KANSL1:NSF:WNT3:MFHAS1:ERI1:MSRA:RP1L1:SOX7:SOX7:PINX1:XKR6:MTMR9:FAM167A:BLK:DEFB135 | |||||||||||||||||||
6 | GWAScatalog | Handedness (Left-handed vs. non-left-handed) | 11 | 7 | 6.35E-10 | 6.41E-08 | STH:KANSL1:ARL17B:LRRC37A:LRRC37A2:ARL17A:NSF | |||||||||||||||||||
7 | GWAScatalog | Handedness (Right-handed vs. non-right-handed) | 11 | 7 | 6.35E-10 | 6.41E-08 | STH:KANSL1:ARL17B:LRRC37A:LRRC37A2:ARL17A:NSF | |||||||||||||||||||
8 | GWAScatalog | Lateral ventricular volume in normal aging | 10 | 6 | 1.90E-08 | 1.64E-06 | MLLT10:NUAK1:C16orf95:TRIOBP:AMZ1:GNA12 | |||||||||||||||||||
9 | GWAScatalog | Social communication problems | 28 | 8 | 9.37E-08 | 7.73E-06 | TRIM27:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR5V1:OR12D3 | |||||||||||||||||||
10 | GWAScatalog | General cognitive ability | 190 | 17 | 8.39E-07 | 4.91E-05 | GATAD2B:ARHGAP27:MAPT:WNT3:FOXP1:BANK1:SLC39A8:ATXN1:BTN3A2:BTN2A2:BTN3A1:BTN2A1:HMGN4:ABT1:POM121L2:HIST1H2BN:OR5V1 | |||||||||||||||||||
11 | GWAScatalog | Hippocampal subfield CA4 volume | 11 | 5 | 1.90E-06 | 0.000101274 | FAM53B:METTL10:FAM175B:MSRB3:ASTN2 | |||||||||||||||||||
12 | GWAScatalog | Dentate gyrus granule cell layer volume | 11 | 5 | 1.90E-06 | 0.000101274 | FAM53B:METTL10:FAM175B:MSRB3:ASTN2 | |||||||||||||||||||
13 | GWAScatalog | Lentiform nucleus volume | 6 | 4 | 3.10E-06 | 0.000152036 | GATAD2B:DENND4B:SLC39A1:EPB41L2 | |||||||||||||||||||
14 | GWAScatalog | Parkinson's disease | 166 | 15 | 3.28E-06 | 0.000156659 | GBA:SYT11:BMP4:ARHGAP27:PLEKHM1:CRHR1:SPPL2C:MAPT:STH:KANSL1:NSF:WNT3:MAGI1:ZNF184:HIST1H2BL | |||||||||||||||||||
15 | GWAScatalog | Intracranial volume | 7 | 4 | 7.11E-06 | 0.000311375 | CRHR1:MAPT:STH:CENPW | |||||||||||||||||||
16 | GWAScatalog | Alzheimer's disease in APOE e4- carriers | 36 | 7 | 1.01E-05 | 0.00041565 | KCNN3:CRHR1:MAPT:KANSL1:WNT3:FNIP1:ACSL6 | |||||||||||||||||||
17 | GWAScatalog | Subcortical brain region volumes | 15 | 5 | 1.15E-05 | 0.00046306 | MSRB3:CRHR1:MAPT:STH:CENPW | |||||||||||||||||||
18 | GWAScatalog | Reaction time | 39 | 7 | 1.76E-05 | 0.00061287 | MAPT:KANSL1:ARL17B:LRRC37A2:ARL17A:NSF:WNT3 | |||||||||||||||||||
19 | GWAScatalog | Neuroticism | 149 | 13 | 2.15E-05 | 0.000722157 | HEXIM1:ARHGAP27:PLEKHM1:CRHR1:SPPL2C:MAPT:STH:KANSL1:MAGI1:CENPW:MFHAS1:ERI1:XKR6 | |||||||||||||||||||
20 | GWAScatalog | Total hippocampal volume | 17 | 5 | 2.28E-05 | 0.000753331 | FAM53B:METTL10:FAM175B:MSRB3:ASTN2 | |||||||||||||||||||
21 | GWAScatalog | Hippocampal subfield CA3 volume | 9 | 4 | 2.47E-05 | 0.000773698 | FAM53B:METTL10:FAM175B:MSRB3 | |||||||||||||||||||
22 | GWAScatalog | Hippocampal subfield CA1 volume | 10 | 4 | 4.05E-05 | 0.001185743 | FAM53B:METTL10:FAM175B:MSRB3 | |||||||||||||||||||
23 | GWAScatalog | Schizophrenia | 727 | 33 | 5.09E-05 | 0.001466837 | MED8:OTUD7B:C1orf54:C1orf51:MRPS21:RPRD2:TRIM8:ARL3:CDH11:HEXIM1:MAGI1:FOXP1:BANK1:SLC39A8:BTN3A2:BTN2A2:BTN3A1:POM121L2:ZNF184:HIST1H2AJ:ZKSCAN4:NKAPL:ZSCAN31:ZKSCAN3:ZSCAN23:TRIM27:ZNF311:OR12D3:UBD:GABBR1:ERI1:MSRA:BNIP3L | |||||||||||||||||||
24 | GWAScatalog | Dentate gyrus molecular layer volume | 12 | 4 | 9.23E-05 | 0.002426629 | FAM53B:METTL10:FAM175B:MSRB3 | |||||||||||||||||||
25 | GWAScatalog | Headache | 27 | 5 | 0.000249293 | 0.005800853 | MRVI1:CRHR1:MAPT:BTN2A2:ASTN2 | |||||||||||||||||||
26 | GWAScatalog | Intelligence (MTAG) | 246 | 14 | 0.000963592 | 0.018030104 | NSF:WNT3:FOXP1:BANK1:SLC39A8:BTN2A2:BTN3A1:BTN2A1:BTN1A1:ABT1:ZNF322:POM121L2:HIST1H2BN:CENPW | |||||||||||||||||||
27 | GWAScatalog | Adventurousness | 141 | 10 | 0.000987472 | 0.018288378 | EFNA4:FAM189B:FOXP1:BANK1:SLC39A8:OR14J1:MFHAS1:PINX1:MTMR9:BNC2 | |||||||||||||||||||
28 | GWAScatalog | Hippocampal tail volume | 11 | 3 | 0.001447304 | 0.025364137 | FAM53B:METTL10:FAM175B | |||||||||||||||||||
29 | GO_bp | GO_DNA_PACKAGING | 196 | 17 | 1.30E-06 | 0.009520015 | ASH1L:CHMP1A:PHF23:H1F0:HIST1H2BL:HIST1H3H:HIST1H2BM:HIST1H4J:HIST1H4K:HIST1H2BN:HIST1H1B:HIST1H3I:HIST1H4L:HIST1H3J:HIST1H2BO:CENPW:MCPH1 | http://www.gsea-msigdb.org/gsea/msigdb/cards/GO_DNA_PACKAGING | ||||||||||||||||||
30 | GWAScatalog | Body fat distribution (leg fat ratio) | 223 | 52 | 9.04E-39 | 1.64E-35 | WNT2B:ST7L:CAPZA1:MOV10:SF3B4:MTMR11:OTUD7B:DCST2:DCST1:ADAM15:EFNA4:EFNA3:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:GBA:FAM189B:SCAMP3:CLK2:HCN3:PKLR:FDPS:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:SYT11:KIAA0907:RXFP4:ARHGEF2:SSR2:CCDC91:NFAT5:NQO1:NOB1:WWP2:MMP24:EIF6:FAM83C:UQCC1:GDF5:HHIP:AMZ1:GNA12:BNC2 | |||||||||||||||||||
31 | GWAScatalog | Body fat distribution (trunk fat ratio) | 236 | 49 | 5.46E-34 | 4.95E-31 | WNT2B:ST7L:CAPZA1:MOV10:SF3B4:MTMR11:OTUD7B:DCST2:DCST1:ADAM15:EFNA4:EFNA3:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:GBA:FAM189B:SCAMP3:CLK2:HCN3:PKLR:FDPS:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:SYT11:KIAA0907:RXFP4:ARHGEF2:SSR2:CCDC91:MMP24:EIF6:FAM83C:UQCC1:GDF5:HHIP:AMZ1:GNA12:XKR6:BNC2 | |||||||||||||||||||
32 | GWAScatalog | Blood protein levels | 1656 | 91 | 4.24E-17 | 1.92E-14 | TIE1:MRPS21:RPRD2:TARS2:MCL1:GOLPH3L:HORMAD1:CTSS:ARNT:CREB3L4:SYT11:CRTAC1:ARL3:CHRDL2:EVL:SRL:CDH11:NQO1:DPEP1:FANCA:TNFSF12:SHBG:FN1:EDEM2:UQCC1:GDF5OS:GDF5:BANK1:P4HA2:PDLIM4:BTN3A3:BTN2A1:BTN1A1:HMGN4:ABT1:ZNF322:HIST1H2BL:HIST1H2AI:HIST1H3H:HIST1H2AJ:HIST1H2BM:HIST1H4J:HIST1H4K:HIST1H2AK:HIST1H2BN:HIST1H2AL:HIST1H1B:HIST1H3I:HIST1H4L:HIST1H2AM:HIST1H2BO:OR2B2:ZNF165:ZSCAN16:ZKSCAN8:ZSCAN9:NKAPL:PGBD1:ZSCAN31:ZKSCAN3:ZSCAN12:ZSCAN23:GPX6:SCAND3:TRIM27:C6orf100:ZNF311:OR2W1:OR2B3:OR2J3:OR2J2:OR14J1:OR5V1:OR12D3:OR11A1:OR10C1:OR2H1:MAS1L:UBD:GABBR1:SFRP4:ANGPT2:ANGPT1:TNFRSF11B:MED22:RPL7A:SURF1:SURF2:SURF4:REXO4:ADAMTS13 | |||||||||||||||||||
33 | GWAScatalog | Height | 798 | 53 | 3.09E-13 | 1.12E-10 | CAPZA1:SV2A:SF3B4:MTMR11:OTUD7B:KCNN3:DCST1:PAPPA2:SUFU:CCDC91:SOCS2:TRIM13:KCNRG:DLEU1:ALDH1A2:WWP2:SPATA33:ANKRD13B:SLC6A4:ACBD4:ANKFN1:MMP24:EIF6:FAM83C:UQCC1:GDF5OS:GDF5:FOXP1:HHIP:ANAPC10:OTUD4:PDZD2:FBN2:P4HA2:PDLIM4:SLC22A5:ZNF322:OR2B2:OR2J3:OR5V1:UBD:GABBR1:ANKS1A:TCP11:SUPT3H:RUNX2:CENPW:L3MBTL3:AMZ1:GNA12:BNC2:LPAR1:PAPPA | |||||||||||||||||||
34 | GWAScatalog | Crohn's disease | 625 | 45 | 1.44E-12 | 3.74E-10 | EFNA3:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:GBA:FAM189B:SCAMP3:CLK2:HCN3:PKLR:FDPS:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:SYT11:KIAA0907:RXFP4:ARHGEF2:SSR2:FAM53B:METTL10:FAM175B:FOXP1:BANK1:SLC39A8:FNIP1:ACSL6:IL3:CSF2:P4HA2:PDLIM4:SLC22A4:SLC22A5:C5orf56:IRF1:UBD:GABBR1 | |||||||||||||||||||
35 | GWAScatalog | Lung function (FVC) | 157 | 22 | 3.46E-12 | 7.84E-10 | TBX15:MCL1:ENSA:KCNK2:CCDC91:MSRB3:DLEU1:WWP2:CLDN7:TNFSF12-TNFSF13:CRHR1:KANSL1:WNT3:ANKFN1:UQCC1:FOXP1:EPHA3:ZNF184:ZKSCAN3:RUNX2:CENPW:AGMO | |||||||||||||||||||
36 | GWAScatalog | Male-pattern baldness | 250 | 27 | 6.57E-12 | 1.33E-09 | FOXD2:TBX15:WARS2:FAM53B:METTL10:FAM175B:LGR4:ALX4:PLCD3:ACBD4:HEXIM1:HEXIM2:ARHGAP27:PLEKHM1:CRHR1:SPPL2C:MAPT:STH:KANSL1:ARL17B:LRRC37A2:ARL17A:NSF:WNT3:SUPT3H:CENPW:ANGPT1 | |||||||||||||||||||
37 | GWAScatalog | Bone mineral density (paediatric, skull) | 17 | 9 | 1.94E-11 | 3.53E-09 | LGR4:LIN7C:CENPW:EYA4:CPED1:WNT16:FAM3C:TNFRSF11B:COLEC10 | |||||||||||||||||||
38 | GWAScatalog | Squamous cell lung carcinoma | 110 | 18 | 2.32E-11 | 3.82E-09 | KCNN3:BTN3A2:BTN3A3:ZNF322:ZNF184:OR2B2:OR2B6:ZNF165:PGBD1:ZSCAN12:GPX6:SCAND3:C6orf100:ZNF311:OR2J3:OR2J2:OR14J1:REXO4 | |||||||||||||||||||
39 | GWAScatalog | Estimated glomerular filtration rate | 489 | 37 | 3.86E-11 | 5.83E-09 | FOXD2:RHOC:PPM1J:MRPS21:TRIM46:MUC1:MTX1:EXOC6:CYP26C1:CYP26A1:SUFU:FAM53B:METTL10:DCDC1:DLEU1:BMP4:NFAT5:NQO1:WWP2:DPEP1:CHMP1A:SLC6A4:SPTBN1:CALCRL:EDEM2:SLC22A4:SUPT3H:L3MBTL3:EYA4:PRKAG2:MCPH1:MFHAS1:MSRA:XKR6:BLK:ASTN2:MED22 | |||||||||||||||||||
40 | GWAScatalog | Lung cancer in ever smokers | 129 | 19 | 4.33E-11 | 6.04E-09 | LMNA:BTN3A2:BTN2A1:HMGN4:ABT1:ZNF322:ZNF184:OR2B2:OR2B6:ZSCAN31:ZSCAN23:SCAND3:TRIM27:ZNF311:OR2J3:OR2J2:OR14J1:UBD:GABBR1 | |||||||||||||||||||
41 | GWAScatalog | Sarcoidosis (Lofgren's syndrome vs non-Lofgren's syndrome) | 33 | 11 | 5.24E-11 | 6.79E-09 | ZNF184:ZNF165:ZKSCAN3:ZSCAN12:TRIM27:C6orf100:OR2B3:OR2J3:OR12D3:OR12D2:MAS1L | |||||||||||||||||||
42 | GWAScatalog | Inflammatory bowel disease | 727 | 46 | 6.70E-11 | 8.10E-09 | EFNA3:EFNA3:EFNA1:SLC50A1:DPM3:KRTCAP2:TRIM46:MUC1:THBS3:MTX1:GBA:FAM189B:SCAMP3:CLK2:HCN3:PKLR:FDPS:RUSC1:ASH1L:MSTO1:YY1AP1:DAP3:GON4L:SYT11:KIAA0907:RXFP4:ARHGEF2:SSR2:FAM53B:METTL10:FAM175B:HEXIM1:FOXP1:BANK1:SLC39A8:FNIP1:ACSL6:IL3:CSF2:P4HA2:PDLIM4:SLC22A4:SLC22A5:C5orf56:IRF1:AMZ1:GNA12 | |||||||||||||||||||
43 | GWAScatalog | Heel bone mineral density | 749 | 45 | 5.80E-10 | 6.41E-08 | WNT2B:TBX15:OTUD7B:THBS3:CYP26A1:FAM175B:LGR4:CCDC91:MSRB3:DLEU1:DOCK9:BMP4:NFAT5:CD68:SHBG:CORO6:SSH2:ANKFN1:SPTBN1:CALCRL:HHIP:OTUD4:FBN2:TRIM27:SUPT3H:SOBP:L3MBTL3:EPB41L2:EYA4:ARID1B:AMZ1:AGMO:MEOX2:EPDR1:SFRP4:SHFM1:C7orf76:CPED1:WNT16:FAM3C:MCPH1:TNFRSF11B:COLEC10:BNC2:PAPPA:ASTN2 | |||||||||||||||||||
44 | GWAScatalog | Red vs. brown/black hair color | 18 | 8 | 1.59E-09 | 1.52E-07 | DPEP1:CHMP1A:FANCA:SPIRE2:TCF25:MC1R:TUBB3:TUBB3:DEF8 | |||||||||||||||||||
45 | GWAScatalog | Alcohol use disorder (total score) | 29 | 9 | 6.37E-09 | 5.78E-07 | PLEKHM1:CRHR1:SPPL2C:MAPT:STH:KANSL1:NSF:WNT3:SLC39A8 | |||||||||||||||||||
46 | GWAScatalog | Rhegmatogenous retinal detachment | 20 | 7 | 1.26E-07 | 9.95E-06 | ADAMTSL4:MCL1:ENSA:GOLPH3L:HORMAD1:CTSS:ARNT | |||||||||||||||||||
47 | GWAScatalog | Lung cancer | 187 | 18 | 1.33E-07 | 1.01E-05 | BTN3A1:ABT1:ZNF322:ZNF184:HIST1H2BL:HIST1H2BO:OR2B2:PGBD1:ZSCAN31:ZSCAN12:ZSCAN23:SCAND3:C6orf100:ZNF311:OR2J2:OR14J1:UBD:GABBR1 | |||||||||||||||||||
48 | GWAScatalog | FEV1 | 153 | 16 | 2.14E-07 | 1.55E-05 | MCL1:CCDC91:MSRB3:DLEU1:DOCK9:WWP2:CLDN7:TNFSF12-TNFSF13:ANKFN1:UQCC1:FOXP1:ZNF184:AGMO:DEFB136:DEFB135:ASTN2 | |||||||||||||||||||
49 | GWAScatalog | Lung function (FEV1) | 74 | 11 | 5.11E-07 | 3.57E-05 | SV2A:MCL1:ENSA:CCDC91:MSRB3:CRHR1:KANSL1:WNT3:HHIP:OTUD4:ZKSCAN3 | |||||||||||||||||||
50 | GWAScatalog | Systolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 109 | 13 | 6.54E-07 | 4.32E-05 | WNT2B:CRTAC1:SLC2A4:TNFSF12:TNFSF13:MFHAS1:ERI1:MSRA:SOX7:SOX7:PINX1:FAM167A:BLK:DPYSL2 | |||||||||||||||||||
51 | GWAScatalog | Systolic blood pressure x smoking status (ever vs never) interaction (2df test) | 92 | 12 | 6.66E-07 | 4.32E-05 | WNT2B:CRTAC1:SLC2A4:TNFSF12:TNFSF13:MFHAS1:ERI1:MSRA:SOX7:SOX7:PINX1:FAM167A:BLK | |||||||||||||||||||
52 | GWAScatalog | Waist-to-hip ratio adjusted for body mass index | 110 | 13 | 7.28E-07 | 4.45E-05 | TBX15:WARS2:DCST2:MUC1:PAPPA2:SPRYD7:DLEU1:BMP4:CALCRL:UQCC1:GDF5:SPATA5:HHIP | |||||||||||||||||||
53 | GWAScatalog | Intraocular pressure | 351 | 24 | 7.36E-07 | 4.45E-05 | ST7L:CAPZA1:EXOC6:CYP26A1:ADAMTS8:PRTG:CDH11:FANCA:NSF:WNT3:SPTBN1:TRIOBP:H1F0:FOXP1:FBN2:P4HA2:SUPT3H:RUNX2:CENPW:BBS9:PRKAG2:MCPH1:ANGPT2:ANGPT1 | |||||||||||||||||||
54 | GWAScatalog | Lumbar spine bone mineral density | 52 | 9 | 1.51E-06 | 8.55E-05 | LIN7C:MAPT:SPTBN1:SUPT3H:EPDR1:NME8:CPED1:WNT16:TNFRSF11B | |||||||||||||||||||
55 | GWAScatalog | Diastolic blood pressure x smoking status (current vs non-current) interaction (2df test) | 104 | 12 | 2.51E-06 | 0.000130362 | WNT2B:CRTAC1:SLC2A4:TNFSF12:TNFSF13:ARID1B:MFHAS1:ERI1:MSRA:SOX7:SOX7:PINX1:DPYSL2 | |||||||||||||||||||
56 | GWAScatalog | Diastolic blood pressure | 601 | 32 | 2.78E-06 | 0.00013996 | WNT2B:ST7L:CAPZA1:MOV10:UBAP2L:ARL3:DCDC1:ADAMTS8:TRIM13:WWP2:DPEP1:CHMP1A:SLC2A4:PLCD3:FN1:ELP6:EPHA3:BANK1:SLC39A8:FBN2:SLC22A5:C5orf56:IRF1:BTN3A3:HIST1H4L:HIST1H3J:CENPW:SHFM1:C7orf76:PRKAG2:MCPH1:BLK:DPYSL2 | |||||||||||||||||||
57 | GWAScatalog | Lung function (FEV1/FVC) | 170 | 15 | 4.40E-06 | 0.000204948 | C1orf54:KRTCAP2:DOCK9:BMP4:TFAP4:SSH2:EFCAB5:HHIP:C5orf56:ZNF184:ZKSCAN3:RUNX2:DEFB136:DEFB135:ASTN2 | |||||||||||||||||||
58 | GWAScatalog | Birth weight | 265 | 19 | 5.36E-06 | 0.000243157 | TBX15:KCNN3:DCST2:LMNA:PAPPA2:MSRB3:CLDN7:SLC2A4:TNFSF12-TNFSF13:KCNJ16:EDEM2:HHIP:CENPW:L3MBTL3:AMZ1:GNA12:MCPH1:LPAR1:PAPPA | |||||||||||||||||||
59 | GWAScatalog | Low tan response | 23 | 6 | 7.21E-06 | 0.000311375 | CHMP1A:FANCA:SPIRE2:MC1R:DEF8:BNC2 | |||||||||||||||||||
60 | GWAScatalog | Empathy quotient | 14 | 5 | 7.79E-06 | 0.000328885 | GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4 | |||||||||||||||||||
61 | GWAScatalog | Peak expiratory flow | 102 | 11 | 1.27E-05 | 0.000500741 | C1orf54:KRTCAP2:CCDC91:MSRB3:BMP4:SSH2:UQCC1:ZNF184:DEFB136:DEFB135:ASTN2 | |||||||||||||||||||
62 | GWAScatalog | Daytime sleep phenotypes | 186 | 15 | 1.31E-05 | 0.000507057 | HHIP:GPX6:SCAND3:TRIM27:C6orf100:ZNF311:OR2B3:OR2J1:OR2J3:OR2J2:OR5V1:OR12D3:OR12D2:AMZ1:GNA12 | |||||||||||||||||||
63 | GWAScatalog | Ulna and radius bone mineral density | 8 | 4 | 1.40E-05 | 0.000515671 | UBD:GABBR1:WNT16:FAM3C | |||||||||||||||||||
64 | GWAScatalog | Bone mineral density (paediatric, upper limb) | 8 | 4 | 1.40E-05 | 0.000515671 | CENPW:CPED1:WNT16:FAM3C | |||||||||||||||||||
65 | GWAScatalog | Pulse pressure | 651 | 32 | 1.42E-05 | 0.000515671 | WNT2B:PAPPA2:ARHGAP12:KIF5B:TRIM8:ARL3:ADAMTS8:CDH11:NFAT5:WWP2:SLC2A4:NMT1:PLCD3:KANSL1:ARL17B:ARL17A:FN1:GDF5:NOL12:TRIOBP:FOXP1:FBN2:HIST1H4L:HIST1H3J:PGBD1:CENPW:ARID1B:PRKAG2:MSRA:BLK:BNC2:PAPPA | |||||||||||||||||||
66 | GWAScatalog | Systolic blood pressure | 748 | 35 | 1.60E-05 | 0.000569164 | SZT2:WNT2B:ST7L:CAPZA1:MOV10:ARHGAP12:KIF5B:SUFU:ARL3:ADAMTS8:CDH11:NOB1:DPEP1:SLC2A4:NMT1:PLCD3:ACBD4:HEXIM1:HEXIM2:KANSL1:ARL17B:ARL17A:ZSWIM2:FN1:FOXP1:EPHA3:BANK1:SLC39A8:FBN2:OR2B6:CENPW:EPB41L2:PRKAG2:MSRA:BLK | |||||||||||||||||||
67 | GWAScatalog | Hand grip strength | 149 | 13 | 2.15E-05 | 0.000722157 | MLLT10:CRTAC1:CDH11:NFAT5:WWP2:SPPL2C:KANSL1:FOXP1:DHFRL1:BANK1:SLC39A8:TRIM27:FAM3C | |||||||||||||||||||
68 | GWAScatalog | Barrett's esophagus | 9 | 4 | 2.47E-05 | 0.000773698 | ALDH1A2:FOXP1:MSRA:BLK | |||||||||||||||||||
69 | GWAScatalog | Skin pigmentation traits | 9 | 4 | 2.47E-05 | 0.000773698 | SPATA33:FANCA:MC1R:BNC2 | |||||||||||||||||||
70 | GWAScatalog | Diastolic blood pressure x smoking status (ever vs never) interaction (2df test) | 91 | 10 | 2.66E-05 | 0.00081948 | WNT2B:SLC2A4:TNFSF12:TNFSF13:MFHAS1:ERI1:MSRA:SOX7:SOX7:PINX1:DPYSL2 | |||||||||||||||||||
71 | GWAScatalog | Idiopathic pulmonary fibrosis | 18 | 5 | 3.10E-05 | 0.000939256 | CRHR1:SPPL2C:MAPT:STH:KANSL1 | |||||||||||||||||||
72 | GWAScatalog | Pediatric bone mineral content (radius) | 4 | 3 | 3.93E-05 | 0.001168769 | CPED1:WNT16:FAM3C | |||||||||||||||||||
73 | GWAScatalog | Bone ultrasound measurement (broadband ultrasound attenuation) | 20 | 5 | 5.42E-05 | 0.001537611 | SPTBN1:WNT16:MFHAS1:XKR6:MTMR9 | |||||||||||||||||||
74 | GWAScatalog | Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction) | 80 | 9 | 5.58E-05 | 0.001557654 | TBX15:WARS2:SF3B4:SUFU:CCDC91:HHIP:SLC22A4:ANKS1A:GNA12 | |||||||||||||||||||
75 | GWAScatalog | Waist circumference adjusted for BMI (adjusted for smoking behaviour) | 82 | 9 | 6.79E-05 | 0.001866459 | TBX15:WARS2:SF3B4:SUFU:CCDC91:HHIP:SLC22A4:ANKS1A:GNA12 | |||||||||||||||||||
76 | GWAScatalog | Multiple system atrophy | 21 | 5 | 6.99E-05 | 0.00189374 | LOXL4:CRHR1:MAPT:WNT3:FBN2 | |||||||||||||||||||
77 | GWAScatalog | White blood cell count | 195 | 14 | 9.06E-05 | 0.002417692 | VSTM4:SUFU:FAM53B:SSH2:CCDC12:SETD2:SLC22A4:ATXN1:UBD:GABBR1:SOX7:SOX7:PINX1:LPAR1:MED22 | |||||||||||||||||||
78 | GWAScatalog | Urea levels | 5 | 3 | 9.66E-05 | 0.002505368 | MTX1:DCDC1:PRKAG2 | |||||||||||||||||||
79 | GWAScatalog | Squamous cell carcinoma | 24 | 5 | 0.000138432 | 0.003538794 | SPATA33:MC1R:DEF8:FOXP1:BNC2 | |||||||||||||||||||
80 | GWAScatalog | Waist circumference adjusted for body mass index | 204 | 14 | 0.000146139 | 0.003683931 | WNT2B:TBX15:WARS2:SF3B4:MTMR11:KCNN3:SUFU:CCDC91:HHIP:SLC22A4:ANKS1A:AMZ1:GNA12:BNC2 | |||||||||||||||||||
81 | GWAScatalog | Risk-taking tendency (4-domain principal component model) | 91 | 9 | 0.00015308 | 0.003806018 | TMEM180:PCCA:NQO1:STH:KANSL1:FOXP1:NSUN3:SLC39A8:ZSCAN23 | |||||||||||||||||||
82 | GWAScatalog | Infant length | 14 | 4 | 0.000180264 | 0.004421351 | SF3B4:GDF5:HHIP:CENPW | |||||||||||||||||||
83 | GWAScatalog | Gastric adenocarcinoma (histologically verified) | 6 | 3 | 0.000190152 | 0.00456216 | MUC1:MTX1:HCN3 | |||||||||||||||||||
84 | GWAScatalog | Chin dimples | 74 | 8 | 0.000191033 | 0.00456216 | TBX15:ADAM15:BMP4:TNFSF12:TNFSF13:SUPT3H:SHFM1:C7orf76:BNC2 | |||||||||||||||||||
85 | GWAScatalog | Bone mineral density (paediatric, total body less head) | 15 | 4 | 0.00024164 | 0.005695807 | CENPW:CPED1:WNT16:FAM3C | |||||||||||||||||||
86 | GWAScatalog | Hip circumference adjusted for BMI | 191 | 13 | 0.00027121 | 0.006230954 | MOV10:MTMR11:DCDC1:CCDC91:DLEU1:SPATA33:GDF5:HHIP:OTUD4:CENPW:L3MBTL3:EYA4:GNA12 | |||||||||||||||||||
87 | GWAScatalog | Age at first birth | 28 | 5 | 0.000298152 | 0.006764318 | GATAD2B:DENND4B:CRTC2:SLC39A1:CREB3L4 | |||||||||||||||||||
88 | GWAScatalog | Coagulation factor levels | 7 | 3 | 0.000327435 | 0.007247495 | MED22:C9orf96:ADAMTS13 | |||||||||||||||||||
89 | GWAScatalog | Remission after SSRI treatment in MDD or neuroticism | 7 | 3 | 0.000327435 | 0.007247495 | PLEKHM1:MSRA:XKR6 | |||||||||||||||||||
90 | GWAScatalog | Anthropometric traits | 29 | 5 | 0.000353937 | 0.007670123 | SV2A:SF3B4:DLEU1:GDF5OS:GDF5 | |||||||||||||||||||
91 | GWAScatalog | Offspring birth weight | 147 | 11 | 0.000354981 | 0.007670123 | KCNN3:DCST2:PAPPA2:CLDN7:SLC2A4:EDEM2:HHIP:L3MBTL3:AMZ1:GNA12:LPAR1 | |||||||||||||||||||
92 | GWAScatalog | Itch intensity from mosquito bite | 63 | 7 | 0.00040498 | 0.008493929 | SPATA5:FNIP1:SLC22A4:C5orf56:IRF1:RUNX2:FAM167A | |||||||||||||||||||
93 | GWAScatalog | Sense of smell | 17 | 4 | 0.000407147 | 0.008493929 | KANSL1:LRRC37A:LRRC37A2:NSF | |||||||||||||||||||
94 | GWAScatalog | Barrett's esophagus or Esophageal adenocarcinoma | 17 | 4 | 0.000407147 | 0.008493929 | ALDH1A2:FOXP1:MSRA:BLK | |||||||||||||||||||
95 | GWAScatalog | Retinal vascular caliber | 18 | 4 | 0.000514603 | 0.010512963 | SOX7:SOX7:PINX1:XKR6:MTMR9 | |||||||||||||||||||
96 | GWAScatalog | Waist-to-hip ratio adjusted for BMI in inactive individuals | 8 | 3 | 0.000515512 | 0.010512963 | TBX15:WARS2:PAPPA2 | |||||||||||||||||||
97 | GWAScatalog | Waist-to-hip ratio adjusted for BMI | 346 | 18 | 0.000562042 | 0.011334523 | TBX15:WARS2:KIF5B:TMEM180:ACTR1A:SUFU:TRIM8:ARL3:DLEU1:KCNJ16:EDEM2:MMP24:EIF6:FAM83C:UQCC1:GDF5:ANAPC10:ABCE1 | |||||||||||||||||||
98 | GWAScatalog | Joint mobility (Beighton score) | 34 | 5 | 0.000759079 | 0.014735593 | PRTG:CRHR1:GDF5:MSRA:XKR6 | |||||||||||||||||||
99 | GWAScatalog | Bone mineral density (paediatric, lower limb) | 9 | 3 | 0.000760905 | 0.014735593 | CPED1:WNT16:FAM3C | |||||||||||||||||||
100 | GWAScatalog | Spine bone size | 9 | 3 | 0.000760905 | 0.014735593 | CHRDL2:UQCC1:GDF5 | |||||||||||||||||||